HUT59384A - Process for producing new thiadiazine oxoderivatives - Google Patents
Process for producing new thiadiazine oxoderivativesInfo
- Publication number
- HUT59384A HUT59384A HU913501D HU350190D HUT59384A HU T59384 A HUT59384 A HU T59384A HU 913501 D HU913501 D HU 913501D HU 350190 D HU350190 D HU 350190D HU T59384 A HUT59384 A HU T59384A
- Authority
- HU
- Hungary
- Prior art keywords
- lower alkyl
- chem
- alkyl group
- hydrogen
- oxoderivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
- C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
- C07D273/04—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Detergent Compositions (AREA)
- Saccharide Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898903130A GB8903130D0 (en) | 1989-02-11 | 1989-02-11 | Substituted pyridazinones |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU913501D0 HU913501D0 (en) | 1992-02-28 |
| HUT59384A true HUT59384A (en) | 1992-05-28 |
| HU206692B HU206692B (en) | 1992-12-28 |
Family
ID=10651554
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU913501D HU206692B (en) | 1989-02-11 | 1990-02-09 | Process for producing new oxo-thiadiazine derivative |
| HU90747A HU204797B (en) | 1989-02-11 | 1990-02-09 | Process for producing oxo derivatives of pyridazine, triazine, oxodiazine and thiadiazine |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU90747A HU204797B (en) | 1989-02-11 | 1990-02-09 | Process for producing oxo derivatives of pyridazine, triazine, oxodiazine and thiadiazine |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US5019575A (hu) |
| EP (1) | EP0383449B1 (hu) |
| JP (1) | JP3011955B2 (hu) |
| CN (1) | CN1036265C (hu) |
| AT (1) | ATE127456T1 (hu) |
| AU (1) | AU619648B2 (hu) |
| CA (1) | CA2009678C (hu) |
| CZ (1) | CZ286036B6 (hu) |
| DD (1) | DD293112A5 (hu) |
| DE (1) | DE69022078T2 (hu) |
| DK (1) | DK0383449T3 (hu) |
| ES (1) | ES2078939T3 (hu) |
| FI (1) | FI96511C (hu) |
| GB (2) | GB8903130D0 (hu) |
| GR (1) | GR3017510T3 (hu) |
| HU (2) | HU206692B (hu) |
| LT (1) | LT3769B (hu) |
| LU (1) | LU90921I2 (hu) |
| NO (2) | NO178067C (hu) |
| NZ (1) | NZ232257A (hu) |
| PT (1) | PT93111B (hu) |
| RU (3) | RU2048467C1 (hu) |
| SK (1) | SK55790A3 (hu) |
| ZA (1) | ZA90681B (hu) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8824458D0 (en) * | 1988-10-19 | 1988-11-23 | Orion Yhtymae Oy | Substituted pyridazinones |
| IE62890B1 (en) * | 1988-12-06 | 1995-03-08 | Hafslund Nycomed Pharma | New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure |
| GB8903130D0 (en) * | 1989-02-11 | 1989-03-30 | Orion Yhtymae Oy | Substituted pyridazinones |
| GB2251615B (en) * | 1991-01-03 | 1995-02-08 | Orion Yhtymae Oy | (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile |
| GB2266841A (en) * | 1992-05-06 | 1993-11-17 | Orion Yhtymae Oy | Compounds for use as anti-ischemic medicaments |
| DE4239540A1 (de) * | 1992-11-25 | 1994-05-26 | Asta Medica Ag | Neue heterocyclische Verbindungen mit antiasthmatischer/antiallergischer, entzündungshemmender, positiv inotroper und blutdrucksenkender Wirkung |
| TW309520B (hu) * | 1994-04-26 | 1997-07-01 | Mitsubishi Chem Corp | |
| DE19514568A1 (de) | 1995-04-20 | 1996-10-24 | Merck Patent Gmbh | Arylalkyl-pyridazinone |
| GB9606474D0 (en) * | 1996-03-27 | 1996-06-05 | Orion Yhytmo Oy | Method for obtaining pure enantiomers of a pyridazinone derivative |
| GB9626472D0 (en) | 1996-12-20 | 1997-02-05 | Aperia Anita C | New use of comt inhibitors |
| FI973804A (fi) * | 1997-09-26 | 1999-03-27 | Orion Yhtymae Oy | Levosimendaanin oraalisia koostumuksia |
| FI980901A (fi) * | 1998-04-23 | 1999-10-24 | Orion Yhtymae Oyj | Levosimendaania säädellysti vapauttavia oraalisia koostumuksia |
| FI980902A (fi) | 1998-04-23 | 1999-10-24 | Orion Yhtymae Oyj | Levosimendaanin stabiileja koostumuksia |
| FI105389B (fi) * | 1998-04-23 | 2000-08-15 | Orion Yhtymae Oyj | Menetelmä levosimendaaniannon siedettävyyden seuraamiseksi |
| FI104718B (fi) * | 1998-06-18 | 2000-03-31 | Orion Yhtymae Oyj | [[4-(2-atsido-3-metyyli-5-oksotetrahydrofuran-2-yyli)fenyyli]hydratsono]propaanidinitriili käytettäväksi referenssiaineena levosimendaanierien analyysissä |
| FI20000577A0 (fi) | 2000-03-13 | 2000-03-13 | Orion Yhtymae Oy | Pyridatsinyylifenyylihydratsoneja |
| FI20002525A (fi) | 2000-11-17 | 2002-05-18 | Orion Yhtymae Oyj | Tulehduksenvastaisia aineita |
| WO2002072099A1 (fr) * | 2001-03-14 | 2002-09-19 | Mitsubishi Pharma Corporation | Agent therapeutique et / ou prophylactique pour la cardiopathie ischemique diabetique |
| WO2004087641A1 (ja) * | 2003-03-31 | 2004-10-14 | Daiichi Pharmaceutical Co., Ltd. | ヒドラゾン誘導体 |
| DE102004011512B4 (de) | 2004-03-08 | 2022-01-13 | Boehringer Ingelheim Vetmedica Gmbh | Pharmazeutische Zubereitung enthaltend Pimobendan |
| EP1579862A1 (en) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
| US8980894B2 (en) | 2004-03-25 | 2015-03-17 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure |
| US20060293395A1 (en) * | 2004-05-28 | 2006-12-28 | Weil Max H | Methods for treating a mammal before, during and after cardiac arrest |
| EP1951227B1 (en) | 2005-11-14 | 2017-04-12 | Boehringer Ingelheim Vetmedica GmbH | Use of pimobendan for the treatment of asymptomatic (occult) heart failure |
| NZ574873A (en) | 2006-07-25 | 2012-03-30 | Cephalon Inc | Pyridazinone derivatives as h3 inhibitors |
| EP1920785A1 (en) | 2006-11-07 | 2008-05-14 | Boehringer Ingelheim Vetmedica Gmbh | Liquid preparation comprising a complex of pimobendan and cyclodextrin |
| FR2917975B1 (fr) | 2007-06-26 | 2009-10-16 | Ceva Sante Animale Sa | Compositions et traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains |
| CA2645772A1 (en) * | 2007-12-05 | 2009-06-05 | Tagawa Greenhouse Enterprises, Llc | Collapsible support apparatus and methods |
| US8664252B2 (en) | 2008-11-25 | 2014-03-04 | Boehringer Ingelheim Vetmedica Gmbh | Phosphodiesterase type III (PDE III) inhibitors or CA2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy |
| EP2825159B1 (en) | 2012-03-15 | 2022-06-22 | Boehringer Ingelheim Vetmedica GmbH | Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof |
| EA034395B1 (ru) * | 2013-01-18 | 2020-02-04 | Бристол-Майерс Сквибб Компани | Фталазиноны и изохинолиноны в качестве ингибиторов rock |
| MX2016000727A (es) | 2013-07-19 | 2016-04-13 | Boehringer Ingelheim Vetmed | Composicion farmaceutica acuosa liquida que contiene derivados de ciclodextrina eterificada con conservante. |
| HUE056143T2 (hu) | 2013-12-04 | 2024-01-28 | Boehringer Ingelheim Vetmedica Gmbh | Pimobendán javított gyógyászati készítményei |
| US10537570B2 (en) | 2016-04-06 | 2020-01-21 | Boehringer Ingelheim Vetmedica Gmbh | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease |
| EP3424908A1 (en) | 2017-07-07 | 2019-01-09 | Melody Healthcare Pvt. Ltd. | Process for preparation of levosimendan |
| KR102128509B1 (ko) * | 2018-12-19 | 2020-07-01 | 한국과학기술연구원 | 말단 아민기에 아릴 또는 헤테로아릴기가 치환된 신규한 히드라존 유도체 및 이의 용도 |
| CN111548310B (zh) * | 2020-05-12 | 2021-07-02 | 成都欣捷高新技术开发股份有限公司 | 一种左西孟旦钠晶型及其制备方法 |
| US11760730B2 (en) | 2021-01-11 | 2023-09-19 | Navinta, Llc | Process for the preparation of high purity Levosimendan |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3432507A (en) * | 1963-12-04 | 1969-03-11 | Upjohn Co | Certain diazatricyclododecadienones and their preparation |
| DE3172252D1 (en) * | 1980-11-14 | 1985-10-17 | Ici Plc | Heterocyclic compounds |
| US4353905A (en) * | 1981-09-17 | 1982-10-12 | Warner-Lambert Company | Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones |
| US4495185A (en) * | 1981-11-12 | 1985-01-22 | Imperial Chemical Industries, Plc | 1,2,4-Triazin-3(2H) ones |
| JPS58113180A (ja) * | 1981-12-28 | 1983-07-05 | Mitsui Toatsu Chem Inc | ピリダジノン誘導体 |
| US4581356A (en) * | 1983-03-22 | 1986-04-08 | Fujisawa Pharmaceutical Co., Ltd. | Triazine derivatives, and pharmaceutical compositions comprising the same |
| GB8310435D0 (en) * | 1983-04-18 | 1983-05-25 | Fujisawa Pharmaceutical Co | Triazine derivatives |
| JPS59196874A (ja) * | 1983-04-22 | 1984-11-08 | Fujisawa Pharmaceut Co Ltd | トリアジン誘導体 |
| US4599332A (en) * | 1983-12-07 | 1986-07-08 | Warner-Lambert Company | 4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]-ethenyl]-3(2H)-pyridazinones and related compounds |
| JPS61158969A (ja) * | 1984-12-24 | 1986-07-18 | ワーナー‐ランバート・コンパニー | ４，５‐ジヒドロ‐４，４‐ジアルキル‐６‐（置換）フエニル‐３（２ｈ）‐ピリダジノン類 |
| US4656170A (en) * | 1985-05-28 | 1987-04-07 | Warner-Lambert Company | N-[4-[2-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)ethenyl]phenyl]acetamide and related compounds |
| US4946842A (en) * | 1985-07-05 | 1990-08-07 | Smith Kline & French Laboratories Limited | Novel guanidino pyridazinones as cardiac stimulants |
| DE3531658A1 (de) * | 1985-09-05 | 1987-03-12 | Boehringer Mannheim Gmbh | Heterocyclisch substituierte indole, zwischenprodukte, verfahren zu ihrer herstellung und arzneimittel |
| GB8603780D0 (en) * | 1986-02-15 | 1986-03-19 | Smith Kline French Lab | Chemical compounds |
| US4898862A (en) * | 1986-03-20 | 1990-02-06 | Sankyo Company Limited | 1,2,4-triazinone derivatives, their preparation and use |
| IT1208003B (it) * | 1987-01-08 | 1989-06-01 | Isf Spa | Procedimento per preparare derivati alcossi alchiliden, idrazino, piridazinici. |
| DE3706427A1 (de) * | 1987-02-27 | 1988-09-08 | Boehringer Mannheim Gmbh | Neue substituierte 3h-indole, zwischenprodukte, verfahren zu ihrer herstellung sowie arzneimittel |
| DE3728491A1 (de) * | 1987-08-26 | 1989-03-09 | Heumann Pharma Gmbh & Co | Dihydropyridazinon-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| JP2717687B2 (ja) * | 1988-02-13 | 1998-02-18 | 日本曹達株式会社 | ピリダジノン誘導体及びその製造方法 |
| GB8903130D0 (en) * | 1989-02-11 | 1989-03-30 | Orion Yhtymae Oy | Substituted pyridazinones |
-
1989
- 1989-02-11 GB GB898903130A patent/GB8903130D0/en active Pending
-
1990
- 1990-01-24 NO NO900336A patent/NO178067C/no not_active IP Right Cessation
- 1990-01-26 GB GB9001853A patent/GB2228004B/en not_active Expired - Lifetime
- 1990-01-26 NZ NZ232257A patent/NZ232257A/en unknown
- 1990-01-29 DE DE69022078T patent/DE69022078T2/de not_active Expired - Lifetime
- 1990-01-29 AT AT90300875T patent/ATE127456T1/de active
- 1990-01-29 EP EP90300875A patent/EP0383449B1/en not_active Expired - Lifetime
- 1990-01-29 DK DK90300875.3T patent/DK0383449T3/da active
- 1990-01-29 ES ES90300875T patent/ES2078939T3/es not_active Expired - Lifetime
- 1990-01-30 ZA ZA90681A patent/ZA90681B/xx unknown
- 1990-02-06 SK SK557-90A patent/SK55790A3/sk not_active IP Right Cessation
- 1990-02-06 CZ CS90557A patent/CZ286036B6/cs not_active IP Right Cessation
- 1990-02-08 AU AU49296/90A patent/AU619648B2/en not_active Expired
- 1990-02-08 FI FI900613A patent/FI96511C/fi active Protection Beyond IP Right Term
- 1990-02-09 JP JP2031339A patent/JP3011955B2/ja not_active Expired - Lifetime
- 1990-02-09 DD DD90337728A patent/DD293112A5/de not_active IP Right Cessation
- 1990-02-09 PT PT93111A patent/PT93111B/pt not_active IP Right Cessation
- 1990-02-09 CA CA002009678A patent/CA2009678C/en not_active Expired - Lifetime
- 1990-02-09 US US07/477,530 patent/US5019575A/en not_active Expired - Lifetime
- 1990-02-09 RU SU904743235A patent/RU2048467C1/ru active
- 1990-02-09 HU HU913501D patent/HU206692B/hu unknown
- 1990-02-09 HU HU90747A patent/HU204797B/hu unknown
- 1990-02-10 CN CN90100645A patent/CN1036265C/zh not_active Expired - Lifetime
-
1991
- 1991-03-15 US US07/670,338 patent/US5122524A/en not_active Expired - Lifetime
- 1991-05-05 RU SU914895242A patent/RU1836362C/ru active
-
1992
- 1992-06-29 RU SU925011896A patent/RU2068844C1/ru active
-
1993
- 1993-09-28 LT LTIP1233A patent/LT3769B/lt not_active IP Right Cessation
-
1995
- 1995-09-22 GR GR950402628T patent/GR3017510T3/el unknown
-
2001
- 2001-11-19 NO NO2001020C patent/NO2001020I1/no unknown
-
2002
- 2002-05-17 LU LU90921C patent/LU90921I2/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT59384A (en) | Process for producing new thiadiazine oxoderivatives | |
| ES8706146A1 (es) | Un procedimiento para preparar derivados de piridina | |
| ES2132284T3 (es) | Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa. | |
| EP0258729A3 (en) | Dihydropyridine derivatives, process for their preparation and their use | |
| NO892170L (no) | Buten- eller propensyrederivater og fremgangsmaate for deres fremstilling. | |
| MY106474A (en) | Guanidine derivatives. | |
| EP0242070A3 (en) | Phenyl-acrylic acid ester derivatives, process for their preparation and their use as fungicides | |
| HUT42277A (en) | Herbicides containing as active subtance derivatives of new 1-aryl-4-nitro-pirasole and process for production of the active substances | |
| HUT50354A (en) | Process for producing new s-adenosylmethionine decarboxilase inhibitors | |
| EP0449195A3 (en) | Aminobenzene compounds, their production and use | |
| FR2529891B1 (hu) | ||
| MY101938A (en) | Benzothiazoline fungicides | |
| JO1274B1 (en) | Pyridine derivatives | |
| ATE160144T1 (de) | Pyridazinon derivate, herstellungsverfahren und verwendung | |
| MY101878A (en) | 1,3,4-thiadiazole | |
| RO96412B1 (ro) | Procedeu pentru prepararea unor derivati de oxadiazol |